Koyfin Home > Directory > Health Care > Amphastar Pharma > Total Equity

Amphastar Pharma Total Equity Chart (AMPH)

Amphastar Pharma annual/quarterly Total Equity from 2014 to 2018.
  • Amphastar Pharma Total Equity for the quarter ending December 12, 2018 was $364m a 10.22% increase of 37m year over year
  • Amphastar Pharma Total Equity for the last 12 months ending December 12, 2018 was $364m a 10.22% increase of 37m year over year
  • Amphastar Pharma Annual Total Equity for 2018 was $364m a 9.25% increase of 34m from 2017
  • Amphastar Pharma Annual Total Equity for 2017 was $331m a 0.42% increase of 1m from 2016
  • Amphastar Pharma Annual Total Equity for 2016 was $329m a 10.25% increase of 34m from 2015
Other Balance Sheet Metrics:
  • Amphastar Pharma Total Assets for the quarter ending December 12, 2018 was $514m a 12.42% increase of 64m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Total Equity Data

12/2018$364m
09/2018$341m
06/2018$321m
03/2018$327m
12/2017$337m
09/2017$331m
06/2017$333m
03/2017$326m
12/2016$329m
09/2016$328m

Annual AMPH Total Equity Data

2018$364m
2017$331m
2016$329m
2015$296m
2014$282m
2013$252m